but the weak stock market for small biotechnology firms in 2002 and 2003 stripped away many of those benefits.
但在2002-2003年间,小生物技术公司股票萎靡不振,追蹤股票的优点蕩然无存。
in japan, the combination of expiring stimulus measures, a weak stock market and a government proposal to double the national sales tax to 10% to reduce steep deficits has been a drag on growth.